1 Heart Failure Therapeutics Market Overview 1.1 Product Overview and Scope of Heart Failure Therapeutics 1.2 Heart Failure Therapeutics Segment by Type 1.2.1 Global Heart Failure Therapeutics Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Diagnosis 1.2.3 Prognosis 1.2.4 Treatment Options and Treatment Algorithm 1.3 Heart Failure Therapeutics Segment by Application 1.3.1 Heart Failure Therapeutics Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Medical Research Organization 1.4 Global Heart Failure Therapeutics Market Size Estimates and Forecasts 1.4.1 Global Heart Failure Therapeutics Revenue 2016-2027 1.4.2 Global Heart Failure Therapeutics Sales 2016-2027 1.4.3 Heart Failure Therapeutics Market Size by Region: 2016 Versus 2021 Versus 2027 2 Heart Failure Therapeutics Market Competition by Manufacturers 2.1 Global Heart Failure Therapeutics Sales Market Share by Manufacturers (2016-2021) 2.2 Global Heart Failure Therapeutics Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Heart Failure Therapeutics Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Heart Failure Therapeutics Manufacturing Sites, Area Served, Product Type 2.5 Heart Failure Therapeutics Market Competitive Situation and Trends 2.5.1 Heart Failure Therapeutics Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Heart Failure Therapeutics Players Market Share by Revenue 2.5.3 Global Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Heart Failure Therapeutics Retrospective Market Scenario by Region 3.1 Global Heart Failure Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Heart Failure Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Heart Failure Therapeutics Market Facts & Figures by Country 3.3.1 North America Heart Failure Therapeutics Sales by Country 3.3.2 North America Heart Failure Therapeutics Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Heart Failure Therapeutics Market Facts & Figures by Country 3.4.1 Europe Heart Failure Therapeutics Sales by Country 3.4.2 Europe Heart Failure Therapeutics Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Heart Failure Therapeutics Market Facts & Figures by Region 3.5.1 Asia Pacific Heart Failure Therapeutics Sales by Region 3.5.2 Asia Pacific Heart Failure Therapeutics Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Heart Failure Therapeutics Market Facts & Figures by Country 3.6.1 Latin America Heart Failure Therapeutics Sales by Country 3.6.2 Latin America Heart Failure Therapeutics Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Heart Failure Therapeutics Market Facts & Figures by Country 3.7.1 Middle East and Africa Heart Failure Therapeutics Sales by Country 3.7.2 Middle East and Africa Heart Failure Therapeutics Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Heart Failure Therapeutics Historic Market Analysis by Type 4.1 Global Heart Failure Therapeutics Sales Market Share by Type (2016-2021) 4.2 Global Heart Failure Therapeutics Revenue Market Share by Type (2016-2021) 4.3 Global Heart Failure Therapeutics Price by Type (2016-2021) 5 Global Heart Failure Therapeutics Historic Market Analysis by Application 5.1 Global Heart Failure Therapeutics Sales Market Share by Application (2016-2021) 5.2 Global Heart Failure Therapeutics Revenue Market Share by Application (2016-2021) 5.3 Global Heart Failure Therapeutics Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Bayer 6.1.1 Bayer Corporation Information 6.1.2 Bayer Description and Business Overview 6.1.3 Bayer Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Bayer Product Portfolio 6.1.5 Bayer Recent Developments/Updates 6.2 Cynokinetics 6.2.1 Cynokinetics Corporation Information 6.2.2 Cynokinetics Description and Business Overview 6.2.3 Cynokinetics Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Cynokinetics Product Portfolio 6.2.5 Cynokinetics Recent Developments/Updates 6.3 Les Laboratoires Servier 6.3.1 Les Laboratoires Servier Corporation Information 6.3.2 Les Laboratoires Servier Description and Business Overview 6.3.3 Les Laboratoires Servier Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Les Laboratoires Servier Product Portfolio 6.3.5 Les Laboratoires Servier Recent Developments/Updates 6.4 Merck & Co. 6.4.1 Merck & Co. Corporation Information 6.4.2 Merck & Co. Description and Business Overview 6.4.3 Merck & Co. Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Merck & Co. Product Portfolio 6.4.5 Merck & Co. Recent Developments/Updates 6.5 Novartis 6.5.1 Novartis Corporation Information 6.5.2 Novartis Description and Business Overview 6.5.3 Novartis Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Novartis Product Portfolio 6.5.5 Novartis Recent Developments/Updates 6.6 Procoralan 6.6.1 Procoralan Corporation Information 6.6.2 Procoralan Description and Business Overview 6.6.3 Procoralan Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Procoralan Product Portfolio 6.6.5 Procoralan Recent Developments/Updates 6.7 Bristol-Myers Squibb Company 6.6.1 Bristol-Myers Squibb Company Corporation Information 6.6.2 Bristol-Myers Squibb Company Description and Business Overview 6.6.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bristol-Myers Squibb Company Product Portfolio 6.7.5 Bristol-Myers Squibb Company Recent Developments/Updates 6.8 Cardiorentis AG 6.8.1 Cardiorentis AG Corporation Information 6.8.2 Cardiorentis AG Description and Business Overview 6.8.3 Cardiorentis AG Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Cardiorentis AG Product Portfolio 6.8.5 Cardiorentis AG Recent Developments/Updates 6.9 CVie Therapeutics Limited 6.9.1 CVie Therapeutics Limited Corporation Information 6.9.2 CVie Therapeutics Limited Description and Business Overview 6.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.9.4 CVie Therapeutics Limited Product Portfolio 6.9.5 CVie Therapeutics Limited Recent Developments/Updates 6.10 Orion Corporation 6.10.1 Orion Corporation Corporation Information 6.10.2 Orion Corporation Description and Business Overview 6.10.3 Orion Corporation Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Orion Corporation Product Portfolio 6.10.5 Orion Corporation Recent Developments/Updates 6.11 PhaseBio Pharmaceuticals 6.11.1 PhaseBio Pharmaceuticals Corporation Information 6.11.2 PhaseBio Pharmaceuticals Heart Failure Therapeutics Description and Business Overview 6.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.11.4 PhaseBio Pharmaceuticals Product Portfolio 6.11.5 PhaseBio Pharmaceuticals Recent Developments/Updates 6.12 Market Segment by Product Type 6.12.1 Market Segment by Product Type Corporation Information 6.12.2 Market Segment by Product Type Heart Failure Therapeutics Description and Business Overview 6.12.3 Market Segment by Product Type Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Market Segment by Product Type Product Portfolio 6.12.5 Market Segment by Product Type Recent Developments/Updates 6.13 B-Blockers 6.13.1 B-Blockers Corporation Information 6.13.2 B-Blockers Heart Failure Therapeutics Description and Business Overview 6.13.3 B-Blockers Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.13.4 B-Blockers Product Portfolio 6.13.5 B-Blockers Recent Developments/Updates 6.14 Calcium Channel Blockers 6.14.1 Calcium Channel Blockers Corporation Information 6.14.2 Calcium Channel Blockers Heart Failure Therapeutics Description and Business Overview 6.14.3 Calcium Channel Blockers Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Calcium Channel Blockers Product Portfolio 6.14.5 Calcium Channel Blockers Recent Developments/Updates 6.15 Cardiac Glycosides 6.15.1 Cardiac Glycosides Corporation Information 6.15.2 Cardiac Glycosides Heart Failure Therapeutics Description and Business Overview 6.15.3 Cardiac Glycosides Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Cardiac Glycosides Product Portfolio 6.15.5 Cardiac Glycosides Recent Developments/Updates 6.16 Diuretics 6.16.1 Diuretics Corporation Information 6.16.2 Diuretics Heart Failure Therapeutics Description and Business Overview 6.16.3 Diuretics Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Diuretics Product Portfolio 6.16.5 Diuretics Recent Developments/Updates 6.17 Morphine 6.17.1 Morphine Corporation Information 6.17.2 Morphine Heart Failure Therapeutics Description and Business Overview 6.17.3 Morphine Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Morphine Product Portfolio 6.17.5 Morphine Recent Developments/Updates 6.18 Vasodilators/Nitrates 6.18.1 Vasodilators/Nitrates Corporation Information 6.18.2 Vasodilators/Nitrates Heart Failure Therapeutics Description and Business Overview 6.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Vasodilators/Nitrates Product Portfolio 6.18.5 Vasodilators/Nitrates Recent Developments/Updates 7 Heart Failure Therapeutics Manufacturing Cost Analysis 7.1 Heart Failure Therapeutics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Heart Failure Therapeutics 7.4 Heart Failure Therapeutics Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Heart Failure Therapeutics Distributors List 8.3 Heart Failure Therapeutics Customers 9 Heart Failure Therapeutics Market Dynamics 9.1 Heart Failure Therapeutics Industry Trends 9.2 Heart Failure Therapeutics Growth Drivers 9.3 Heart Failure Therapeutics Market Challenges 9.4 Heart Failure Therapeutics Market Restraints 10 Global Market Forecast 10.1 Heart Failure Therapeutics Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Heart Failure Therapeutics by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Heart Failure Therapeutics by Type (2022-2027) 10.2 Heart Failure Therapeutics Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Heart Failure Therapeutics by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Heart Failure Therapeutics by Application (2022-2027) 10.3 Heart Failure Therapeutics Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Heart Failure Therapeutics by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Heart Failure Therapeutics by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Heart Failure Therapeutics Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Heart Failure Therapeutics Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Heart Failure Therapeutics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Heart Failure Therapeutics Covered in This Study Table 5. Global Heart Failure Therapeutics Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Heart Failure Therapeutics Sales Share by Manufacturers (2016-2021) Table 7. Global Heart Failure Therapeutics Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Heart Failure Therapeutics Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Heart Failure Therapeutics Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Heart Failure Therapeutics Manufacturing Sites and Area Served Table 11. Manufacturers Heart Failure Therapeutics Product Type Table 12. Global Heart Failure Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Heart Failure Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Therapeutics as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Heart Failure Therapeutics Sales by Region (2016-2021) & (K Units) Table 16. Global Heart Failure Therapeutics Sales Market Share by Region (2016-2021) Table 17. Global Heart Failure Therapeutics Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Heart Failure Therapeutics Sales by Country (2016-2021) & (K Units) Table 19. North America Heart Failure Therapeutics Sales Market Share by Country (2016-2021) Table 20. North America Heart Failure Therapeutics Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Heart Failure Therapeutics Revenue Market Share by Country (2016-2021) Table 22. Europe Heart Failure Therapeutics Sales by Country (2016-2021) & (K Units) Table 23. Europe Heart Failure Therapeutics Sales Market Share by Country (2016-2021) Table 24. Europe Heart Failure Therapeutics Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Heart Failure Therapeutics Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Heart Failure Therapeutics Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Heart Failure Therapeutics Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Heart Failure Therapeutics Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Heart Failure Therapeutics Revenue Market Share by Region (2016-2021) Table 30. Latin America Heart Failure Therapeutics Sales by Country (2016-2021) & (K Units) Table 31. Latin America Heart Failure Therapeutics Sales Market Share by Country (2016-2021) Table 32. Latin America Heart Failure Therapeutics Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Heart Failure Therapeutics Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Heart Failure Therapeutics Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Heart Failure Therapeutics Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Heart Failure Therapeutics Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Heart Failure Therapeutics Revenue Market Share by Country (2016-2021) Table 38. Global Heart Failure Therapeutics Sales (K Units) by Type (2016-2021) Table 39. Global Heart Failure Therapeutics Sales Market Share by Type (2016-2021) Table 40. Global Heart Failure Therapeutics Revenue (Million US$) by Type (2016-2021) Table 41. Global Heart Failure Therapeutics Revenue Share by Type (2016-2021) Table 42. Global Heart Failure Therapeutics Price (USD/Unit) by Type (2016-2021) Table 43. Global Heart Failure Therapeutics Sales (K Units) by Application (2016-2021) Table 44. Global Heart Failure Therapeutics Sales Market Share by Application (2016-2021) Table 45. Global Heart Failure Therapeutics Revenue (Million US$) by Application (2016-2021) Table 46. Global Heart Failure Therapeutics Revenue Share by Application (2016-2021) Table 47. Global Heart Failure Therapeutics Price (USD/Unit) by Application (2016-2021) Table 48. Bayer Corporation Information Table 49. Bayer Description and Business Overview Table 50. Bayer Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Bayer Heart Failure Therapeutics Product Table 52. Bayer Recent Developments/Updates Table 53. Cynokinetics Corporation Information Table 54. Cynokinetics Description and Business Overview Table 55. Cynokinetics Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Cynokinetics Heart Failure Therapeutics Product Table 57. Cynokinetics Recent Developments/Updates Table 58. Les Laboratoires Servier Corporation Information Table 59. Les Laboratoires Servier Description and Business Overview Table 60. Les Laboratoires Servier Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Les Laboratoires Servier Heart Failure Therapeutics Product Table 62. Les Laboratoires Servier Recent Developments/Updates Table 63. Merck & Co. Corporation Information Table 64. Merck & Co. Description and Business Overview Table 65. Merck & Co. Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Merck & Co. Heart Failure Therapeutics Product Table 67. Merck & Co. Recent Developments/Updates Table 68. Novartis Corporation Information Table 69. Novartis Description and Business Overview Table 70. Novartis Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Novartis Heart Failure Therapeutics Product Table 72. Novartis Recent Developments/Updates Table 73. Procoralan Corporation Information Table 74. Procoralan Description and Business Overview Table 75. Procoralan Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Procoralan Heart Failure Therapeutics Product Table 77. Procoralan Recent Developments/Updates Table 78. Bristol-Myers Squibb Company Corporation Information Table 79. Bristol-Myers Squibb Company Description and Business Overview Table 80. Bristol-Myers Squibb Company Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Bristol-Myers Squibb Company Heart Failure Therapeutics Product Table 82. Bristol-Myers Squibb Company Recent Developments/Updates Table 83. Cardiorentis AG Corporation Information Table 84. Cardiorentis AG Description and Business Overview Table 85. Cardiorentis AG Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Cardiorentis AG Heart Failure Therapeutics Product Table 87. Cardiorentis AG Recent Developments/Updates Table 88. CVie Therapeutics Limited Corporation Information Table 89. CVie Therapeutics Limited Description and Business Overview Table 90. CVie Therapeutics Limited Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. CVie Therapeutics Limited Heart Failure Therapeutics Product Table 92. CVie Therapeutics Limited Recent Developments/Updates Table 93. Orion Corporation Corporation Information Table 94. Orion Corporation Description and Business Overview Table 95. Orion Corporation Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Orion Corporation Heart Failure Therapeutics Product Table 97. Orion Corporation Recent Developments/Updates Table 98. PhaseBio Pharmaceuticals Corporation Information Table 99. PhaseBio Pharmaceuticals Description and Business Overview Table 100. PhaseBio Pharmaceuticals Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Table 102. PhaseBio Pharmaceuticals Recent Developments/Updates Table 103. Market Segment by Product Type Corporation Information Table 104. Market Segment by Product Type Description and Business Overview Table 105. Market Segment by Product Type Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Market Segment by Product Type Heart Failure Therapeutics Product Table 107. Market Segment by Product Type Recent Developments/Updates Table 108. B-Blockers Corporation Information Table 109. B-Blockers Description and Business Overview Table 110. B-Blockers Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. B-Blockers Heart Failure Therapeutics Product Table 112. B-Blockers Recent Developments/Updates Table 113. Calcium Channel Blockers Corporation Information Table 114. Calcium Channel Blockers Description and Business Overview Table 115. Calcium Channel Blockers Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Calcium Channel Blockers Heart Failure Therapeutics Product Table 117. Calcium Channel Blockers Recent Developments/Updates Table 118. Cardiac Glycosides Corporation Information Table 119. Cardiac Glycosides Description and Business Overview Table 120. Cardiac Glycosides Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Cardiac Glycosides Heart Failure Therapeutics Product Table 122. Cardiac Glycosides Recent Developments/Updates Table 123. Diuretics Corporation Information Table 124. Diuretics Description and Business Overview Table 125. Diuretics Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Diuretics Heart Failure Therapeutics Product Table 127. Diuretics Recent Developments/Updates Table 128. Morphine Corporation Information Table 129. Morphine Description and Business Overview Table 130. Morphine Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Morphine Heart Failure Therapeutics Product Table 132. Morphine Recent Developments/Updates Table 133. Vasodilators/Nitrates Corporation Information Table 134. Vasodilators/Nitrates Description and Business Overview Table 135. Vasodilators/Nitrates Heart Failure Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Vasodilators/Nitrates Heart Failure Therapeutics Product Table 137. Vasodilators/Nitrates Recent Developments/Updates Table 138. Production Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Heart Failure Therapeutics Distributors List Table 141. Heart Failure Therapeutics Customers List Table 142. Heart Failure Therapeutics Market Trends Table 143. Heart Failure Therapeutics Growth Drivers Table 144. Heart Failure Therapeutics Market Restraints Table 145. Global Heart Failure Therapeutics Sales Forecast by Type (2022-2027) & (K Units) Table 146. Global Heart Failure Therapeutics Sales Market Share Forecast by Type (2022-2027) Table 147. Global Heart Failure Therapeutics Revenue Forecast by Type (2022-2027) & (US$ Million) Table 148. Global Heart Failure Therapeutics Revenue Market Share Forecast by Type (2022-2027) Table 149. Global Heart Failure Therapeutics Sales Forecast by Application (2022-2027) & (K Units) Table 150. Global Heart Failure Therapeutics Sales Market Share Forecast by Application (2022-2027) Table 151. Global Heart Failure Therapeutics Revenue Forecast by Application (2022-2027) & (US$ Million) Table 152. Global Heart Failure Therapeutics Revenue Market Share Forecast by Application (2022-2027) Table 153. Global Heart Failure Therapeutics Sales Forecast by Region (2022-2027) & (K Units) Table 154. Global Heart Failure Therapeutics Sales Market Share Forecast by Region (2022-2027) Table 155. Global Heart Failure Therapeutics Revenue Forecast by Region (2022-2027) & (US$ Million) Table 156. Global Heart Failure Therapeutics Revenue Market Share Forecast by Region (2022-2027) Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Heart Failure Therapeutics Figure 2. Global Heart Failure Therapeutics Market Share by Type in 2020 & 2027 Figure 3. Diagnosis Product Picture Figure 4. Prognosis Product Picture Figure 5. Treatment Options and Treatment Algorithm Product Picture Figure 6. Global Heart Failure Therapeutics Market Share by Application in 2020 & 2027 Figure 7. Hospital Figure 8. Clinic Figure 9. Medical Research Organization Figure 10. Global Heart Failure Therapeutics Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Heart Failure Therapeutics Market Size 2016-2027 (US$ Million) Figure 12. Global Heart Failure Therapeutics Sales 2016-2027 (K Units) Figure 13. Global Heart Failure Therapeutics Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Heart Failure Therapeutics Sales Share by Manufacturers in 2020 Figure 15. Global Heart Failure Therapeutics Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Heart Failure Therapeutics Players: Market Share by Revenue in 2020 Figure 17. Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Heart Failure Therapeutics Sales Market Share by Region (2016-2021) Figure 19. Global Heart Failure Therapeutics Sales Market Share by Region in 2020 Figure 20. Global Heart Failure Therapeutics Revenue Market Share by Region (2016-2021) Figure 21. Global Heart Failure Therapeutics Revenue Market Share by Region in 2020 Figure 22. U.S. Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Heart Failure Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Heart Failure Therapeutics by Type (2016-2021) Figure 47. Sales Market Share of Heart Failure Therapeutics by Application (2016-2021) Figure 48. Sales Market Share of Heart Failure Therapeutics by Application in 2020 Figure 49. Revenue Share of Heart Failure Therapeutics by Application (2016-2021) Figure 50. Revenue Share of Heart Failure Therapeutics by Application in 2020 Figure 51. Manufacturing Cost Structure of Heart Failure Therapeutics Figure 52. Manufacturing Process Analysis of Heart Failure Therapeutics Figure 53. Heart Failure Therapeutics Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Bayer Cynokinetics Les Laboratoires Servier Merck & Co. Novartis Procoralan Bristol-Myers Squibb Company Cardiorentis AG CVie Therapeutics Limited Orion Corporation PhaseBio Pharmaceuticals Market Segment by Product Type B-Blockers Calcium Channel Blockers Cardiac Glycosides Diuretics Morphine Vasodilators/Nitrates